Growth Hormone‑Releasing Hormone (GHRH) Analog | GH Axis, Fat Loss & Metabolic Research | For Research Use Only

Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH), engineered to stimulate pituitary release of endogenous growth hormone (GH). It offers more precise GH stimulation compared to exogenous GH, making it a valuable tool in research focusing on visceral fat reduction, metabolic regulation, and aging-related metabolic decline.

This 10 mg vial is ideal for preclinical studies examining the GH axis, lipid metabolism, and applications in HIV‑associated lipodystrophy and metabolic syndrome models.

🔍 Key Features

• Potentiates Endogenous GH Release via GHRH Pathway

• Supports Visceral Fat Reduction & Body Composition Modulation

• Improves IGF‑1 Levels and Metabolic Function

• Used in Clinical and Preclinical Studies for Lipodystrophy & Aging

• Favors Natural GH Feedback Mechanisms

⚙️ Compound Details

• Compound Name: Tesamorelin Acetate

• CAS Number: 155003‑08‑7

• Molecular Formula: C₁₉₆H₃₀₄N₅₄O₅₈S

• Molecular Weight: ~4949.8 g/mol

• Purity: ≥ 98% (HPLC Verified)

• Form: Lyophilised white/off‑white powder

• Unit Size: 10 mg per vial

🧊 Storage & Handling

• Storage (lyophilised): Store at –20 °C in a dry, dark location

• Reconstitution: Use sterile bacteriostatic water (0.9% saline optional)

• Post‑Reconstitution: Store at 2–8 °C and use within 7–10 days

• Avoid: Heat exposure, light, contamination, and repeated freeze‑thaw cycles

⚠️ For Research Use Only

Tesamorelin – 10 mg is provided exclusively for scientific research and investigational purposes. It is not intended for human or veterinary use, therapeutic application, or diagnosis. To be handled by trained laboratory professionals only.